Skip to main content
Premium Trial:

Request an Annual Quote

Open Spot

The top spot at the US Food and Drug Administration — a key role in the pandemic response — remains vacant as President Joe Biden takes office, Politico reports.

Stephen Hahn resigned as FDA commissioner with the change of power and Janet Woodcock is now serving as the acting commissioner, according to the New York Times

The Biden Administration has not yet nominated a permanent FDA commissioner, and Politico reports that the Biden team has debated who should take on the role for months and that Xavier Becerra, who has been nominated to lead the Department of Health and Human Services, wants a say in the matter. It adds, though, that Woodcock is under consideration, as are Josh Sharfstein, who served as deputy commissioner at FDA during the Obama Administration, and Amy Abernethy, the current principal deputy commissioner.

Steve Grossman, deputy executive director of the Alliance for a Stronger FDA, notes that previous administrations have held off on nominating a permanent FDA head for a few months, but Politico adds that the pandemic has put a spotlight on the agency.

"Sooner is better," Mark McClellan, FDA commissioner during the Bush Administration tells Politico. "Sooner is especially better in a public health emergency. We're not done with this pandemic by any means."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.